BAA Deadlines.pdf
PDF 59 KB Posted
- Attached to
- FY24 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
- Solicitation number
- FDABAA-24-00123
About this file
This document outlines submission deadlines and requirements for a Broad Agency Announcement from the Food and Drug Administration for fiscal year 2024. Optional early concept papers are due by November 6, 2023 with feedback provided. Stage one submittals including checklists, concept papers, and full proposals are due by February 19, 2024 and will be reviewed with favorable concept papers advancing. The open period to submit stage one packages runs from February 20, 2024 through September 30, 2024. Within 30 days of request, offerors must submit stage two revised full proposals responding to prior feedback. Submissions are to be emailed to the specified address by the listed deadlines.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Table 1.pdf | ||
| FY24 BAA Notice v6.0.pdf | ||
| Word Format Attachments.docx | DOCX document | |
| Timeline Tables.pdf | ||
| FY24 BAA Notice v5.0.pdf | ||
| FY24 BAA Notice v4.0.pdf | ||
| BAA Deadlines.pdf | ||
| BAA_FY2023_Awards.pdf | ||
| FY24 BAA Notice v3.0.pdf | ||
| BAA_FY2023_Awards_SAM.pdf | ||
| BAA_FY2023_Awards_SAM.pdf | ||
| Attachment 6 SOW Template.docx | DOCX document | |
| Cost Appendix 8 Preaward Survey Accounting System.pdf | ||
| Cost Appendix 7 Proposal Template.xlsx | XLSX spreadsheet | |
| FY24 BAA Notice v2.0.pdf | ||
| BAA Application Overview.pdf |
Show all 16
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Table 2: Submission deadlines for FY24 BAA
Deadline for submission#
Description What to submit?
How to Submit? What to expect?
11/6/2023 Optional Early Concept Paper
Submission
Free standing Concept Paper
(attachment 4)
~Email subject line “Charge
Area_ FDABAA- 24-00123
Optional Concept Paper”
FDA
recommendation for interest or lack of interest of Full Proposal submission 2/19/2024 Stage I
Submittal Packages for FY24 funding consideration
Checklist (attachment 3), Freestanding Concept Paper (attachment 4), $Freestanding Full Proposal
~Email subject line “Charge Area_ FDABAA- 24-00123 Concept Paper with Full Proposal”
Evaluate Concept Paper and forward Full Proposal of favorable Concept Papers for review
%~Email subject line “BAA Number_ Concept Paper with Full Proposal”
Review Full Proposal
*2/20/2024- 9/30/2024
*Stage I Submittal Packages for open period
*Same as above
*Same as above *Same as above
Within 30 calendar days of FDA request^
Stage II: Revised Full Proposal Submittal Package
Cover Page, Response summary to feedback, Revised Full Proposal
~Email subject line “BAA Number_Revised Full Proposal”
Review of responses and revised Full Proposal
# All submission deadlines indicate 11:59 PM (Eastern Standard Time) ~FDABAA@fda.hhs.gov $Freestanding Full Proposal: Volume I Technical Proposal with appendix (attachment
5) and Volume II Cost Proposal with appendix %Optional Concept Paper with Full Proposal submission FDA recommendation *Open Period: Stage One Submittal Packages received after February 19, 2024 will still be accepted, but due to a lack of lead time and funding availability may not be considered for award in FY24. These submissions may be considered for award in
FY25.
^Unless designated otherwise by the Contracting Officer mailto:FDABAA@fda.hhs.gov
File details come from the government source that posted it. Updated .